Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The rising cost of glaucoma drugs.

× No keyword cloud information.

14 in total

1. Compliance with methodological standards when evaluating ophthalmic diagnostic tests.

Authors: R Harper; B Reeves
Journal: Invest Ophthalmol Vis Sci Date: 1999-07 Impact factor: 4.799

2. Is more always better?

Authors: Anja Tuulonen
Journal: Acta Ophthalmol Scand Date: 2004-08

3. The quality of reporting of diagnostic accuracy studies published in ophthalmic journals.

Authors: M A R Siddiqui; A Azuara-Blanco; J Burr
Journal: Br J Ophthalmol Date: 2005-03 Impact factor: 4.638

4. Changes in medical and surgical treatments of glaucoma between 1997 and 2000 in France.

Authors: C Baudouin; J F Rouland; C Le Pen
Journal: Eur J Ophthalmol Date: 2003-07 Impact factor: 2.597

5. Blindness in patients with treated open-angle glaucoma.

Authors: Philip P Chen
Journal: Ophthalmology Date: 2003-04 Impact factor: 12.079

6. Treatment and vision-related quality of life in the early manifest glaucoma trial.

Authors: Leslie G Hyman; Eugene Komaroff; Anders Heijl; Bo Bengtsson; M Cristina Leske
Journal: Ophthalmology Date: 2005-09 Impact factor: 12.079

Review 7. Medical versus surgical interventions for open angle glaucoma.

Authors: J Burr; A Azuara-Blanco; A Avenell
Journal: Cochrane Database Syst Rev Date: 2005-04-18

8. The Glaucoma Laser Trial (GLT) and glaucoma laser trial follow-up study: 7. Results. Glaucoma Laser Trial Research Group.

Authors:
Journal: Am J Ophthalmol Date: 1995-12 Impact factor: 5.258

9. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial.

Authors: M Cristina Leske; Anders Heijl; Mohamed Hussein; Bo Bengtsson; Leslie Hyman; Eugene Komaroff
Journal: Arch Ophthalmol Date: 2003-01

10. How prostaglandins have changed the medical approach to glaucoma and its costs: an observational study of 2228 patients treated with glaucoma medications.

Authors: Renato De Natale; Eva Draghi; Maria Teresa Dorigo
Journal: Acta Ophthalmol Scand Date: 2004-08

6 in total

1. Personalized Prediction of Glaucoma Progression Under Different Target Intraocular Pressure Levels Using Filtered Forecasting Methods.

Authors: Pooyan Kazemian; Mariel S Lavieri; Mark P Van Oyen; Chris Andrews; Joshua D Stein
Journal: Ophthalmology Date: 2017-12-02 Impact factor: 12.079

2. Cost-effectiveness of medications compared with laser trabeculoplasty in patients with newly diagnosed open-angle glaucoma.

Authors: Joshua D Stein; David D Kim; Will W Peck; Steven M Giannetti; David W Hutton
Journal: Arch Ophthalmol Date: 2012-02-13

3. Progress toward personalized medicine for glaucoma.

Authors: Sayoko E Moroi; Duna A Raoof; David M Reed; Sebastian Zöllner; Zhaohui Qin; Julia E Richards
Journal: Expert Rev Ophthalmol Date: 2009-04

4. Trends in Glaucoma Medication Expenditures under Universal Health Coverage: A National Population-Based Longitudinal Survey in Taiwan.

Authors: Shin-Lin Chiu; Chiao-Lee Chu; Chih-Hsin Muo; Chiu-Liang Chen; Shou-Jen Lan
Journal: J Ophthalmol Date: 2015-06-02 Impact factor: 1.909

5. The cost-effectiveness of medication, laser trabeculoplasty, and trabeculectomy for treatment of open-angle glaucoma in South Korea.

Authors: Jin A Choi; Lina D Song; Seulggie Choi; Sang Min Park; Jin Woo Kwon; Donghyun Jee
Journal: Medicine (Baltimore) Date: 2019-01 Impact factor: 1.889

6. Daily costs of prostaglandin analogues as monotherapy or in fixed combinations with timolol, in Denmark, Finland, Germany and Sweden.

Authors: Anders Bergström; Frédérique Maurel; Claude Le Pen; Emilie Lamure; Michael Kent; Isabelle Bardoulat; Gilles Berdeaux
Journal: Clin Ophthalmol Date: 2009-08-20

6 in total